Physician profile
Michael Thomas
NPI 1588673461
$992.11
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $151 · 2021: $22.34 · 2022: $206 · 2023: $420 · 2024: $18.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392 · Travel and Lodging: $46.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.83 |
| Travel and Lodging | $46.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $306.73 | 2023-2024 | Prodisc C Vivo |
| Si-Bone, INC. | $234.44 | 2019-2020 | |
| Camber Spine Technologies LLC | $115.78 | 2022 | |
| Ossdsign USA Incorporated | $107.76 | 2023 | |
| Zimmer Biomet Holdings, INC. | $41.59 | 2020-2021 | |
| Integrity Implants INC. | $34.84 | 2022 | |
| Stryker Corporation | $27.59 | 2022 | |
| Titan Pharmaceuticals, INC. | $25.50 | 2019 | |
| Theragen, INC. | $24.19 | 2023 | Actastim-S |
| Ermi LLC | $18.47 | 2019 | |
| Orthofix Medical, INC. | $14.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.77 | 2019 | |
| Pfizer INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.